72162-2194-1 |
72162-2194 |
HUMAN PRESCRIPTION DRUG |
Carbidopa and Levodopa |
Carbidopa and Levodopa |
TABLET, EXTENDED RELEASE |
ORAL |
20231215 |
N/A |
ANDA |
ANDA214091 |
Bryant Ranch Prepack |
CARBIDOPA; LEVODOPA |
25 mg/1; 100 mg/1 |
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2194-1) |
0615-8461-39 |
0615-8461 |
HUMAN PRESCRIPTION DRUG |
Carbidopa and Levodopa |
Carbidopa and Levodopa |
TABLET, EXTENDED RELEASE |
ORAL |
20230403 |
N/A |
ANDA |
ANDA214091 |
NCS HealthCare of KY, LLC dba Vangard Labs |
CARBIDOPA; LEVODOPA |
50 mg/1; 200 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8461-39) |
0615-8460-39 |
0615-8460 |
HUMAN PRESCRIPTION DRUG |
Carbidopa and Levodopa |
Carbidopa and Levodopa |
TABLET, EXTENDED RELEASE |
ORAL |
20230328 |
N/A |
ANDA |
ANDA214091 |
NCS HealthCare of KY, LLC dba Vangard Labs |
CARBIDOPA; LEVODOPA |
25 mg/1; 100 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8460-39) |
72162-2193-1 |
72162-2193 |
HUMAN PRESCRIPTION DRUG |
Carbidopa and Levodopa |
Carbidopa and Levodopa |
TABLET, EXTENDED RELEASE |
ORAL |
20231215 |
N/A |
ANDA |
ANDA214091 |
Bryant Ranch Prepack |
CARBIDOPA; LEVODOPA |
50 mg/1; 200 mg/1 |
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2193-1) |
50228-460-01 |
50228-460 |
HUMAN PRESCRIPTION DRUG |
Carbidopa and Levodopa |
Carbidopa and Levodopa |
TABLET, EXTENDED RELEASE |
ORAL |
20211005 |
N/A |
ANDA |
ANDA214091 |
ScieGen Pharmaceuticals Inc |
CARBIDOPA; LEVODOPA |
25 mg/1; 100 mg/1 |
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-460-01) |
50228-461-10 |
50228-461 |
HUMAN PRESCRIPTION DRUG |
Carbidopa and Levodopa |
Carbidopa and Levodopa |
TABLET, EXTENDED RELEASE |
ORAL |
20211005 |
N/A |
ANDA |
ANDA214091 |
ScieGen Pharmaceuticals Inc |
CARBIDOPA; LEVODOPA |
50 mg/1; 200 mg/1 |
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-461-10) |
50228-461-30 |
50228-461 |
HUMAN PRESCRIPTION DRUG |
Carbidopa and Levodopa |
Carbidopa and Levodopa |
TABLET, EXTENDED RELEASE |
ORAL |
20211005 |
N/A |
ANDA |
ANDA214091 |
ScieGen Pharmaceuticals Inc |
CARBIDOPA; LEVODOPA |
50 mg/1; 200 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-461-30) |
50228-460-10 |
50228-460 |
HUMAN PRESCRIPTION DRUG |
Carbidopa and Levodopa |
Carbidopa and Levodopa |
TABLET, EXTENDED RELEASE |
ORAL |
20211005 |
N/A |
ANDA |
ANDA214091 |
ScieGen Pharmaceuticals Inc |
CARBIDOPA; LEVODOPA |
25 mg/1; 100 mg/1 |
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-460-10) |
50228-460-30 |
50228-460 |
HUMAN PRESCRIPTION DRUG |
Carbidopa and Levodopa |
Carbidopa and Levodopa |
TABLET, EXTENDED RELEASE |
ORAL |
20211005 |
N/A |
ANDA |
ANDA214091 |
ScieGen Pharmaceuticals Inc |
CARBIDOPA; LEVODOPA |
25 mg/1; 100 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-460-30) |
50228-461-01 |
50228-461 |
HUMAN PRESCRIPTION DRUG |
Carbidopa and Levodopa |
Carbidopa and Levodopa |
TABLET, EXTENDED RELEASE |
ORAL |
20211005 |
N/A |
ANDA |
ANDA214091 |
ScieGen Pharmaceuticals Inc |
CARBIDOPA; LEVODOPA |
50 mg/1; 200 mg/1 |
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-461-01) |